The Molecular Basis of the Anti-Cyclin D1 Intrabody-Induced Inhibition of Hepatocellular Carcinoma Progression

被引：0
|
作者：
Wu, Yan [1 ]
Cui, An [1 ]
Li, Hanwei [1 ]
Tang, Weiwei [1 ]
Zhang, Ying [1 ]
Yang, Ning [1 ]
Shen, Guannan [1 ]
Ju, Cynthia [2 ]
Li, Guiying [1 ]
机构：
[1] Jilin Univ, Key Lab Mol Enzymol & Engn, Minist Educ, Coll Life Sci, Changchun 130023, Peoples R China
[2] Univ Colorado Denver, Dept Pharmaceut Sci, Aurora, CO USA
来源：
HEPATOLOGY | 2014年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
918
引用
收藏
页码：643A / 644A
页数：2
相关论文
共 50 条
  • [1] Cell cycle inhibition by intracellular delivery of anti-cyclin D1
    Erlanger, B. F.
    Chen, B-X.
    [J]. ANNALS OF ONCOLOGY, 2007, 18 : 31 - 31
  • [2] A specific anti-cyclin D1 intrabody represses breast cancer cell proliferation by interrupting the cyclin D1–CDK4 interaction
    Jialiang Zhao
    Yan Wu
    Tong Xiao
    Cheng Cheng
    Tong Zhang
    Ziyang Gao
    Siyuan Hu
    Ze Ren
    Xinze Yu
    Fang Yang
    Guiying Li
    [J]. Breast Cancer Research and Treatment, 2023, 198 : 555 - 568
  • [3] An intrabody against human cyclin D1 inhibits the growth and proliferation of hepatocellular carcinoma
    Xu, Hongliang
    Wu, Yan
    Li, Bingzhi
    Yang, Dan
    Li, Hanwei
    Wang, Wenhan
    Zhou, Xun
    Ju, Cynthia
    Li, Guiying
    [J]. HEPATOLOGY, 2012, 56 : 606A - 606A
  • [4] A specific anti-cyclin D1 intrabody represses breast cancer cell proliferation by interrupting the cyclin D1-CDK4 interaction
    Zhao, Jialiang
    Wu, Yan
    Xiao, Tong
    Cheng, Cheng
    Zhang, Tong
    Gao, Ziyang
    Hu, Siyuan
    Ren, Ze
    Yu, Xinze
    Yang, Fang
    Li, Guiying
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2023, 198 (03) : 555 - 568
  • [5] Cell cycle inhibition by an anti-cyclin D1 antibody chemically modified for intracellular delivery
    Chen, Bi-Xing
    Erlanger, Bernard F.
    [J]. CANCER LETTERS, 2006, 244 (01) : 71 - 75
  • [6] Anti-cyclin D1 antibody chemically modified for intracellular delivery
    Erlanger, BF
    Chen, BX
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : 31 - 31
  • [7] Cyclin D1 overexpression in hepatocellular carcinoma
    Joo, M
    Kang, YK
    Kim, MR
    Lee, HK
    Jang, JJ
    [J]. LIVER, 2001, 21 (02): : 89 - 95
  • [8] Polymorphisms in cyclin D1 gene and hepatocellular carcinoma
    Zhang, YJ
    Chen, SY
    Chen, CJ
    Santella, RM
    [J]. MOLECULAR CARCINOGENESIS, 2002, 33 (02) : 125 - 129
  • [9] Reciprocal expressions of cyclin E and cyclin D1 in hepatocellular carcinoma
    Jung, YJ
    Lee, KH
    Choi, DW
    Han, CJ
    Jeong, SH
    Kim, KC
    Oh, JW
    Park, TK
    Kim, CM
    [J]. CANCER LETTERS, 2001, 168 (01) : 57 - 63
  • [10] Desferroxamine: An anti-cyclin D1 agent cytoxic against cyclin D1(+) mantle cell lymphoma and multiple myeloma cell lines.
    Epner, EM
    Wright, H
    DeAngelis, K
    Jin, W
    Hui, L
    Clurman, B
    [J]. BLOOD, 2002, 100 (11) : 354A - 354A
12345